{
    "2020-04-26": [
        [
            {
                "time": "",
                "original_text": "贝达药业一季度业绩增152.36% 厄洛替尼专利即将过期风险增加",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "一季度业绩",
                        "152.36%",
                        "厄洛替尼",
                        "专利过期",
                        "风险增加"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}